CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2600
+0.0021 (0.81%)
Oct 10, 2025, 3:58 PM EDT
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $324.84 million as of October 10, 2025. Its market cap has increased by 52.37% in one year.
Market Cap
324.84M
Enterprise Value
340.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.26
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 324.84M, an increase of 5,766.16%. That is a compound annual growth rate of 22.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 324.84M | 141.28% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | 3.21B | 695.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 678.14M |
| Elite Pharmaceuticals | 677.87M |
| Veradigm | 500.94M |
| Northwest Biotherapeutics | 368.34M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 287.67M |
| Silence Therapeutics | 243.25M |
| Jushi Holdings | 167.00M |